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A B S T R A C T
During synthesis, mRNA undergoes a number of modiﬁcations such as capping, splicing and polyadenylation. These processes are coupled with the orderly deposition
of the TREX complex on the mRNA and subsequent recruitment of the NXF1-P15 heterodimer which stimulates the nuclear export of mature mRNAs. mRNAs also
undergo a number of internal modiﬁcations, the most common of which is the N6‑methyladenosine (m6A) modiﬁcation. In this review we discuss the recent evidence
of coupling between the m6A modiﬁcation, RNA processing and export.
1. Introduction
DNA, RNA and proteins can all undergo post synthesis modiﬁcations
allowing for tight regulation and diverse function. In regards to RNA,
over 100 distinct chemical modiﬁcations have been identiﬁed [1]. The
most abundant internal chemical modiﬁcation present within eu-
karyotic mRNA is N6‑methyladenosine (m6A) [2]. Although the m6A
modiﬁcation of mRNA has been known for some time, recent advances
in sequencing technologies have led to an explosion of new research.
Not only discovering the precise distribution of m6A but also the protein
players orchestrating its addition and subsequently carrying out a
variety of m6A dependent functions [3,4]. The major eﬀects of m6A
addition on transcripts appear to be a reduction in their stability and
inﬂuencing the splicing kinetics of nascent pre-mRNAs [5–7]. However,
the addition of m6A also inﬂuences a variety of steps within the life-
cycle of an mRNA. Nuclear processing, export and translation all appear
altered with the addition of m6A [8]. Additionally, the m6A modiﬁca-
tion and its associated proteins have been found to regulate a variety of
cell speciﬁc process. The removal of m6A can result in perturbation of a
cells circadian rhythm, impair embryonic stem cell diﬀerentiation and
disrupt Drosophila sex determination [9–12]. In addition, m6A plays a
role in the control of neurogenesis, DNA damage response pathways
and X chromosome transcriptional inactivation [13–15].
The m6A modiﬁcation appears to play a vital role in the expression
of a certain subset of genes, inﬂuencing many aspects of their expres-
sion [8]. One of the key steps in gene expression is the export of a
mature correctly packaged mRNA from the nucleus through the nuclear
pore to the cytoplasm. The bulk of mRNA is exported from the nucleus
in a Ran-independent manner via the Transcription Export (TREX)
Complex and the nuclear heterodimeric export receptor NXF1-P15
[16]. RNA Polymerase II synthesises pre-mRNA that is then subject to
multiple co- and post-transcriptional processing events, such as 5′
capping, splicing and 3′ polyadenylation [17]. Throughout the mRNA
maturation process, members of the TREX complex are deposited on the
mRNA and culminate in a messenger ribonucleoprotein complex
(mRNP) containing the correct protein composition to bind and hand
over the mRNA to the export receptor NXF1 [18–20]. m6A is found in
pre-mRNA and some of the factors involved in this RNA modiﬁcation
are found in the nuclear speckles, sites where mRNA export factors
reside in the nucleus [21]. Furthermore multiple members of the me-
thylation complex have been found to interact with subunits of the
TREX complex [22]. Therefore, it seems likely that this RNA mod-
iﬁcation might also inﬂuence the export of mRNAs harbouring this
modiﬁcation. This leads us to the purpose of this review, which is
twofold. Firstly, we will discuss the recent m6A literature outlining the
currently proposed pathway and also point out the inconsistencies
present. Following this we will identify the evidence presented
throughout the literature of an overlap between the m6A machinery and
the nuclear mRNA export pathway.
2. m6A pathway
The transcriptome wide mapping of human m6A revealed wide-
spread modiﬁcation covering one third of the transcriptome conﬁned to
the consensus sequence of RRACU [2,3]. The majority of steady state
m6A residing in the RRAC consensus sequence is deposited on target
transcripts with a bias toward longer exons [2,23]. Recent advances
within the ﬁeld have also identiﬁed m6A within intronic regions of
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nascent pre-mRNA clustering around a consensus sequence with a SAG
core [7]. The addition of m6A is carried out by the methyltransferase
complex with its subunits often referred to as ‘writers’. There are also
indications of demethylases, referred to as ‘erasers’, but this is a source
of much debate and will be discussed in due course. The ﬁnal class of
proteins in the m6A pathway are ‘readers’. Readers are responsible for
decoding the m6A mark and conducting further processes on a target
mRNA, often bridging between two cellular pathways. Below we will
discuss the m6A biogenesis pathway, describing its currently identiﬁed
members and their roles. We will also take this opportunity to present
the current inconsistencies within the literature. Fig. 1 illustrates the
currently known m6A pathway.
3. Writer complex
The methyltransferase writer complex is responsible for the co-
transcriptional catalytic addition of m6A to target mRNAs [5,21,24].
The currently deﬁned methyltransferase writer complex comprises
adaptor proteins, RNA binding motif protein 15 (RBM15) and its
paralogue RBM15B, responsible for initial recruitment of the complex
to its target site on a pre-mRNA. The adaptors have also been im-
plicated in an m6A dependent silencing mechanism for X-chromosome
inactivation via XIST [13]. Regulatory members are responsible for the
complex formation, these are Wilms' tumour 1-associating protein
(WTAP) and KIAA1429 (also known as VIRMA) [21,23]. The recently
characterised zinc ﬁnger CCCH domain-containing protein 13
(ZC3H13) has been found to act as a bridge between the adaptor
RBM15 and WTAP [25]. The ﬁnal member of the writer complex is the
catalytic heterodimeric core consisting of Methyltransferase-like pro-
tein 3 (METTL3) and Methyltransferase-like protein 14 (METTL14)
[24].
WTAP is a ubiquitously expressed protein identiﬁed in a yeast–two
hybrid screen associating with splicing factors and was subsequently
linked to mammalian cell cycle progression from G2 to M [26,27].
Additional mass spectrometry studies on the WTAP interactome re-
vealed multiple methyltransferase complex members such as RBM15,
KIAA1429 and METTL3/METTL14, although their role within the m6A
pathway was not clariﬁed at that time [28]. Subsequent work identiﬁed
WTAP as a METTL3/METTL14 binding partner and responsible for the
recruitment of the heterodimer to target transcripts facilitating me-
thylation [21,29]. WTAP does not appear to harbour a catalytic do-
main, however its knockdown resulted in a 6.25-fold decrease in m6A
transcriptome wide, this decrease appears to be as a result of reduced
METTL3 recruitment [21,23].
Proteomic analysis of WTAP revealed another member of the reg-
ulatory component of the methyltransferase complex, KIAA1429 [23].
The knockdown of KIAA1429 results in a fourfold decrease in m6A le-
vels transcriptome wide [23]. Further evidence for KIAA1429 associa-
tion within the m6A pathway arose from studies on the Drosophila or-
thologue Virilizer. Two independent studies implicated Virilizer in the
m6A dependent regulation of sex determination via alternative splicing
[10,11]. KIAA1429 is responsible for recruitment of METTL3 and
METTL14 along with WTAP. Furthermore, it associates with poly-
adenylation cleavage factors and play a role in Poly A site selection for
certain m6A containing transcripts [30].
The protein ZC3H13 is the most recently identiﬁed member of the
methyltransferase complex [25,31]. Knockout of ZC3H13 triggers an
80% reduction in m6A levels transcriptome wide, similar to that of a
METTL3 knockout [25,31]. Interestingly ZC3H13 appears to be re-
quired for RBM15 and WTAP association, but not for the association
between RBM15 and KIAA1429 [25]. ZC3H13 deﬁcient Drosophila S2R
+ cells display an increased intron retention rate as well as an in-
creased usage of alternative 5′ splice sites [25]. Interestingly, the study
by Knuckles et al. suggests the possibility of two compositionally
Fig. 1. The m6A pathway. The methylation is added to the target mRNA molecule in a co-transcriptional manner by the writer complex. The enzymatic activity of the
writer complex is imparted by the METT3/METT14 heterodimer. Once a target RNA molecule has been methylated a reader can speciﬁcally bind the modiﬁcation
and impart further processing upon the molecule.
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distinct complexes; m6A-METTL-associated complex (MACOM), which
comprises of RBM15, ZC3H13, WTAP, KIAA1429 and CBLL1 (HAKAI)
and the m6A–METTL complex (MAC), comprising of METTL3 and
METTL4. Together MACOM and MAC act to trigger the m6A mod-
iﬁcation. However, genetic studies in Drosophila suggest that MACOM
has additional m6A independent functions [25].
The catalytic transfer of a methyl group to nitrogen of an adenosine
is carried out by a tight heterodimeric complex consisting of METTL3
and METTL14 [24]. The methylation donor was identiﬁed as S‑Ade-
nosyl‑methionine (SAM) [24,32]. METTL3 was found to play a role in
circadian rhythm regulation as knockdown of METTL3 results in a
prolonged circadian period due to the reduced nuclear kinetics of
speciﬁc clock genes [12]. Mechanistic details of methylation by the
heterodimer were revealed by crystallographic studies [33–35]. Sur-
prisingly METTL14 appears to have no catalytic activity, instead acting
as a RNA binding scaﬀold to facilitate the METTL3 dependent m6A
modiﬁcation [33]. Initial studies revealed knockdown of either
METTL3 or METTL14 did not yield a dramatic reduction in transcrip-
tional m6A (compared with WTAP) indicating possible redundancy or
that only low levels of the METTL3 enzyme are required for methyla-
tion to occur [23]. However recent publications have indicated the
knockout of METTL3 results in a greater than 90% reduction in m6A
levels [5].
The distribution of m6A within the human and mouse embryonic
stem cell (ESC) transcriptome has revealed a unique methylation de-
pendent regulatory mechanism. Core factors required for pluripotency
were identiﬁed as METTL3 targets [36]. The m6A modiﬁcation is
thought to reduce the stability of speciﬁc mRNAs required for ESCs to
move from a naïve to a primed state [37]. Chromatin associated zinc
ﬁnger protein 217, ZFP217, is responsible for the regulation of core
stem cells genes, and was found to associate with METTL3. High
ZFP217 levels in ESCs result in the sequestering of METTL3 and
therefore a reduction in methylation upon target mRNAs. Upon dif-
ferentiation, ZFP217 levels decrease resulting in the release of METTL3
and its subsequent interaction with METTL14 [9].
4. Erasers
As well as writers the current literature suggests the existence of
m6A demethylases, also known as erasers. With the potential to have
the modiﬁcation added and removed by the writers and erasers, akin to
the epigenetic mechanisms regulating gene expression, the term epi-
transcriptomics was coined [38]. However, recent studies are starting
to cast doubt on the once exciting concept of a general mechanism for
m6A related epitranscriptomics [5,39].
Two possible demethylase enzymes/erasers have been discovered,
FTO and ALKBH5, both are members of the ALKB subfamily of the
superfamily of Fe(II)/2‑oxoglutarate dioxygenases [40,41]. The initial
study connecting ALKBH5 and m6A revealed a demethylase activity
with preference for single stranded RNA/DNA, unlike other ALK family
members that can catalyse the demethylation of double stranded sub-
strates [41]. A subsequent crystallographic study revealed the reason
behind ALKBH5 substrate preference, a loop formation results in a
steric clash with double stranded ribonucleic substrates therefore al-
lowing only single stranded nucleic acids access to the catalytic site
[42]. When assaying the enzymatic activity of ALKBH5, in vitro, using
an m6A-RNA oligomer comprising the RRACU consensus only a 40%
reduction in total m6A was observed post ALKBH5 treatment. Inter-
estingly a non-consensus m6A-control saw a 20% decrease in m6A levels
[41]. Further to this, the knockdown of ALKBH5 in HeLa cells resulted
in a 9% increase in m6A transcriptome wide. One possibility for this
modest eﬀect could be redundancy within the pathway allowing for the
cells to compensate for the loss. A greater eﬀect on m6A levels was
observed when over expressing ALKBH5 in HeLa cells as a ~29% re-
duction in m6A was detected [41]. The study by Zheng and colleagues
showed that ALKBH5 deﬁcient male mice were characterised by
impaired fertility as a result of aberrant spermatogenesis and apoptosis
in the testis [41]. ALKBH5 knockout results in increased m6A deposition
at speciﬁc 3′ splice sites resulting in alternatively spliced 3′ UTRs and
shorter transcripts with a decreased half-life [43].
Interestingly, ALKBH5 and its potential demethylase activity have
been implicated in the tumour initiation of breast cancer stem cells
[44]. Speciﬁcally, Zhang et al., identiﬁed the hypoxia dependent sta-
bilisation of pluripotency factor mRNA of NANOG via ALKBH5 de-
methylation in its 3′ UTR [44]. However, a further study by the same
group identiﬁed a known methyltransferase (METTL3) inhibitor
ZNF217 [9], was expressed in the same hypoxia dependent manner
within breast cancer stem cells and acted upon NANOG [45]. The
subsequent study raises a level of uncertainty of the actions of ALKBH5
upon NANOG in this particular setting, as the observed reduction in
methylation may be a consequence of the METTL3 inhibitor expression.
Another example of ALKBH5 mediated demethylation of m6A was
identiﬁed with the FOXM1 transcript [46]. This study demonstrated the
ALKBH5-FOXM1 pathway as a critical component for Glioblastoma
Stem-like Cell proliferation and tumorigenesis. ALKBH5 was identiﬁed
as acting upon FOXM1 transcript in a unique manner. FOXM1 transcript
demethylation was promoted by the formation of an RNA-RNA duplex
with anti-sense FOXM1 long non-coding RNA (FOXM1-AS) [46]. This
duplex interaction promoting ALKBH5 catalytic activity upon FOXM1
transcript indicates a novel substrate recognition mechanism for the
demethylase.
The second reported m6A demethylase is FTO. As with ALKBH5, the
proposed role of FTO within the m6A pathway has changed since the
ﬁrst identiﬁcation of its potential m6A demethylation activity [40].
Initial data suggested FTO harboured a preference toward 5′ m6A
modiﬁcations [47,48]. However, recent work by Mauer et al. has
identiﬁed the preferential target of FTO is the
N62′‑O‑dimethyladenosine (m6Am) modiﬁcation not m
6A [39]. m6Am is
located adjacent to the mRNA N7‑methylguanosine (m7G) cap and it
was noted transcripts with this modiﬁcation displayed an overall
greater stability. To have the greatest catalytic activity on m6Am, it was
shown FTO requires the presence of the m7G modiﬁcation and tripho-
sphate linker. Furthermore, FTO displays 100 fold greater catalytic
activity for m6Am compared to m
6A [39]. The increase in stability ap-
pears to be imparted upon select m6Am transcripts by a resistance to
mRNA-decapping enzymes [39].
To add to the functional uncertainty regarding demethylases, the
recent study by Ke et al. indicated that the vast majority of m6A is
added to chromatin associated pre-mRNA and persists throughout the
nucleoplasm and cytoplasm. This argues against frequent demethyla-
tion of steady state m6A RNA [5]. However the study does note a very
small portion of m6A peaks present in the chromatin associated RNA
were reduced in frequency in the nucleoplasm [5]. This suggests a
potential demethylase acting prior to nuclear export on a small subset
of mRNAs, but not the vast majority of m6A containing transcripts [5].
There is much work to be done on ALKBH5, and demethylases in
general, to clarify their role within the m6A pathway. It appears from
the current literature ALKBH5 only acts upon a small subset of mRNAs
and although the m6A modiﬁcation resides in the same consensus se-
quence, ALKBH5 may require a unique yet unidentiﬁed recognition
method, exempliﬁed in the FOXM1 study [46].
The case for global epitranscriptomic mRNA regulation is not as
clear cut as initially thought. Further work is required to outline the
speciﬁcities of the identiﬁed demethylases and possibility of identiﬁ-
cation of new ones.
5. Readers
The m6A readers carry out diﬀerent functions once bound to the
transcript (for an in-depth look at the m6A reader proteins consult
Meyer and Jaﬀrey 2017 [49]). A variety of reader proteins have been
discovered, often linking the m6A modiﬁcation with other mRNA
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pathways. Two heterogeneous nuclear ribonucleoproteins (HNRNP)
have been identiﬁed as nuclear located m6A readers, HNRNPA2B1 and
HNRNPC [50,51]. Although they share similar characteristics, HNRNPs
comprise a wide array of diﬀerent domains and therefore carry out an
array of functions [52]. HNRNPA2B1 has been identiﬁed as a direct
nuclear reader of m6A and involved in the control and processing of a
subset of pre-miRNAs [50]. The discovery occurred when an
HNRNPA2B1 knockdown phenocopied the reduction in miRNA ex-
pression also observed in a METTL3 knockdown [50]. Post methylation
HNRNPA2B1 binds to the methylated adenosine and bridges the initial
interaction between pre-miRNA and the microprocessor complex, spe-
ciﬁcally DGCR8 [53,54]. HNRNPC was identiﬁed as an indirect reader
of m6A [51]. The addition of an m6A within a stem loop structure re-
sulted in a change in its thermostability, disrupting the secondary
structure allowing HNRNPC-RNA interactions to occur. This was
termed an m6A-dependent RNA switch and it is noteworthy that
HNRNPC does not directly bind m6A but acts indirectly as a con-
sequence of m6A addition. However, this switch only occurs on a subset
of HNRNPC target RNAs, pre-mRNAs and lncRNAs and is said to in-
ﬂuence splice site selection [51]. The catalogue of m6A readers is ever
expanding, a recent global analysis identiﬁed new m6A readers but also
proteins repelled by m6A [55]. This study identiﬁed FMR1 as a new
reader of m6A, suggesting a link between the mRNA modiﬁcation and
an autism spectrum disorder [55].
YTHDF1/2/3 are cytoplasmic readers that recognise the m6A via an
aromatic cage consisting of two conserved tryptophan residues, located
in the YTH domain [56–59]. Although all identiﬁed cytoplasmic
readers contain a YTH-m6A RNA binding domain they diﬀer in further
domain composition allowing for an array of functions [60]. YTHDF1 is
responsible for ribosomal loading onto m6A transcripts and subse-
quently their expression. This function is apparent as the interactome of
YTHDF1 is heavily populated with translation initiation factors, notably
eIF3 [61]. The YTHDF1 dependent translation initiation mechanism
only occurs on a subset of m6A transcripts [61]. Conversely YTHDF2
destabilises its m6A-mRNA targets in the cytoplasm by directly re-
cruiting them to the CCR4-NOT deadenylase complex [6]. The RNA-
m6A-YTHDF2 complex can be located in the 3′ UTR or open reading
frame and alters the lifetime of transcripts. This degradation me-
chanism is orchestrated by the N-terminus of YTHDF2 whilst its C-
terminal YTH domain binds m6A [62]. This leads to the formation of a
multidimensional cytoplasmic mechanism for select transcript expres-
sion via the m6A modiﬁcation, as YTHDF1 promotes translation whilst
YTHDF2 can induce transcript degradation. Cross talk between these
proteins is evident as they share 50% of their targets [61]. Cellular
response mechanisms upon stress have been found to involve m6A de-
pendent mechanisms. One example is the heat shock induced nuclear
translocation of YTHDF2, resulting in protection of speciﬁc mRNA
targets subsequently allowing for their cytoplasmic expression [63]. A
third member of the cytoplasmic YTH-domain subfamily, YTHDF3, has
been implicated in both translation and degradation [64]. The current
literature paints a methylation dependent regulatory pathway orche-
strated by the cytoplasmic YTH containing proteins.
YTHDC1 (YT521-B) is a nuclear localised YTH domain containing
protein initially described as a splicing associated factor [65]. The
crystal structure of YTHDC1 revealed details of its m6A binding activity.
As is the case with the previously discussed YTH containing proteins,
YTHDC1 binds the modiﬁcation via two tryptophan residues within an
aromatic cage [59]. Interestingly 21% of all YTHDC1 bound transcripts
are shared with YTHDF2 and 13% of all bound targets having a role in
transcriptional regulation [59]. Recently the role of YTHDC1 in splicing
regulation has been investigated in detail, providing mechanistic details
of previously identiﬁed YTHDC1 knockdown phenotypes [65,66].
YTHDC1 was found to bind near splice sites and promote exon inclu-
sion, working cooperatively with splicing factor SRSF3 [66]. Con-
versely Xiao et al. also suggest SRSF10 can bind at similar sites on
mRNA, resulting in the blocking of YTHDC1 mRNA binding therefore
resulting in exon skipping [66,67]. The proposed current competition
model of YTHDC1, SRSF3 and SRSF10 may provide mechanistic rea-
soning for previous results showing exon inclusion is YTHDC1 dosage
dependent, greater expression of YTHDC1 leads to an increase in exon
inclusion [68,69].
Recent studies have built on the work performed by Xiao et al. to
discover m6A is deposited within intronic regions and around splicing
junctions. Loiloupi et al. [7] developed transient N‑6‑methyladenosine
transcriptome sequencing (TNT-seq), a novel approach to identify the
m6A landscape of nascent RNA. This method incorporated a bromour-
idine RNA isolation step prior to m6A RNA isolation, allowing for
analysis of nascent RNA. The resulting data indicated up to 57% of m6A
on nascent RNA resides within introns [7]. They concluded m6A de-
position upon intronic sequences is associated with slowly processed
introns and alternative splicing events, whereas m6A deposition close to
splicing junctions promotes fast splicing. These data indicate m6A
regulates the kinetics of splicing. It was also noted intronic m6A sits
within a SAG core consensus and not the classical RRAC consensus
[3,7]. The SAG core is reminiscent of the SRSF binding motifs consistent
with the role of SRSF3/10 in m6A splicing regulation [66], although it
does not reﬂect the YTHDC1 binding motif [59]. Conversely a study by
Ke et al., demonstrates that whilst the vast majority of m6A is added to
pre-mRNA prior to chromatin dissociation and splicing completion,
very little occurs within introns [5]. Furthermore Ke et al. demon-
strated, only ~10% of m6A sites were within 50 nucleotides of a 5′ or 3′
splice site and cells lacking METTL3 showed few splicing changes.
Moreover, Ke et al. did not observe a universal demethylation event
between chromatin associated RNA and nucleoplasm/cytoplasmic RNA.
The discrepancy between these ﬁnding may be due to the RNA isolation
and sequencing techniques applied: m6A-CLIP vs TNT-seq [5,7]. Fur-
ther studies will be needed to deﬁne the complex pathways associated
with m6A-related RNA biogenesis.
YTHDC1 also plays a role in mRNA export in concert with hypo-
phosphorylated SR proteins and the major export receptor NXF1 [70].
This is the ﬁrst study to oﬀer mechanistic insight into the possible role
of the m6A pathway and mRNA export. In order for us to outline the
data presented throughout the literature on a possible overlap of the
m6A pathway and mRNA export we will give a brief introduction on
mRNA export and its key players.
6. mRNA export
The bulk of mRNA nuclear export is mediated by the TREX complex
and the heterodimeric nuclear export receptor NXF1-P15. TREX is de-
posited on the mRNA through a number of pre- and post-transcriptional
maturation events. Fig. 2 gives an overview of the TREX-NXF1 medi-
ated export pathway. The initial addition of the 5′ m7guanosine (m7G)
cap to nascent pre-mRNAs protects them from the action of 5′-3′ exo-
nucleases [17]. Moreover, the m7G cap confers binding of CBP80 and
CBP20 that form the cap-binding complex (CBC). The action of CBC
binding allows for deposition of TREX components onto the 5′ end of
the mRNA [71,72]. mRNAs undergo co- and post-transcriptional spli-
cing. The excision of introns and fusing of exons results in the formation
of an exon junction complex (EJC) centred ~24 bases upstream from
the exon-exon boundary. The EJC associates with TREX subunits whilst
TREX member UAP56 is involved in spliceosome assembly [73,74].
Polyadenylation of pre-mRNAs at the 3′ terminus is another ma-
turation event that commits the mRNA for nuclear export. A hex-
anucleotide cleavage signal is bound by cleavage and polyadenylation
factors responsible for removal of the downstream RNA. Post cleavage,
Poly A polymerase catalyses the addition of adenosine repeats on the 3′
terminal cleaved mRNA. The adenosine repeats are then bound by
PABPN1, protecting the mRNA from degradation by 3′-5′ exonuclease
[75]. The combination of these processing events leads to the formation
of a correctly packaged messenger ribonucleoparticle (mRNP) that
contains all the licensing signals for nuclear pore translocation
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orchestrated by NXF1.
7. Transcription export complex
TREX is conserved from yeast to humans and is required for mes-
senger ribonucleoprotein particles (mRNP) nuclear export [76,77].
Akin to the spliceosome, the TREX complex undergoes multiple con-
formational and compositional changes. At the core of the TREX com-
plex sits the multimeric THO complex comprised of THOC1,2,3,5,6,7
and DEAD box RNA helicase, UAP56 [78,79]. Export adaptor subunits
of TREX, ALYREF, UIF and LUZP4, aid in the loading and handover of
the packaged mRNA to the nuclear export receptor NXF1 [20,80,81].
Coadaptor subunits of TREX, CHTOP and THOC5, also play a critical
role in NXF1 loading [82].
ALYREF is recruited to the mRNP via UAP56 during splicing in an
ATP dependent manner [19,78]. It contains two UAP56-binding motifs
(UBM) at its N and C-termini. The core of the adaptor consists of an
RNA recognition motif ﬂanked by two disordered arginine rich regions
which are the main RNA binding sites [74]. The arginine rich regions of
ALYREF are also required for NXF1 binding [83]. UAP56 interacting
factor (UIF) is a second export adaptor that contains a UBM. Although
UIF interacts with ALYREF, the interaction is RNA-dependent, therefore
UIF may exist in an alternative TREX complex populating the same
mRNA as an ALYREF containing TREX. UIF recruitment to the mRNA
diﬀers to that of ALYREF. The FACT chromatin remodelling complex is
required for the co-transcriptional loading of UIF but not ALYREF [80].
A third export adaptor, LUZP4, is a cancer testis antigen – a group of
proteins normally restricted to testis which are commonly upregulated
in cancer cells. LUZP4 displays the classical adaptor characteristics
mentioned above, contains a UBM and NXF1s mRNA binding aﬃnity
increases upon association [81]. Members of the serine/arginine (SR)
rich family of proteins can also act as mRNA export adaptors when in a
hypophosphorylated state, this function is independent of their role
within splicing [84].
THOC5 and CHTOP have been identiﬁed as co-adaptor proteins
involved in NXF1 binding and mRNA handover [82,85]. The co-adap-
tors bind to NXF1 co-operatively with adaptors. It is also worth noting
that CHTOP and THOC5 bind to NXF1 in a mutually exclusive manner
[82]. The presence of multiple adaptors and co-adaptors illustrates the
dynamic changes and redundancy within the TREX complex dependent
mRNA export pathway.
A key stage in export of the mRNP is the handover of the mRNA to
the export receptor NXF1. NXF1 consists of ﬁve distinct domains (de-
picted in Fig. 3), the RNA binding domain (RBD), pseudo-RNA re-
cognition motif (ΨRRM), leucine rich region (LRR), NTF2-like (NTF2L)
domain and ubiquitin associated domain (UBA) [86]. The N-terminal
arginine rich RBD is responsible for NXF1 RNA recognition, however it
shows no sequence speciﬁcity [87]. To prevent the export of non-/in-
correctly processed mRNA, NXF1 sequesters its own RNA binding ac-
tivity via intramolecular association of the NTF2L and RBD domains
[20]. Therefore, an mRNA is only handed to NXF1 once associated with
the TREX complex. The mRNA handover is conducted via export
adaptors binding the RBD and ΨRRM whilst export co-adaptors as-
sociate with the NTF2L domain [20]. The association of TREX compo-
nents releases the NXF1 RBD, stabilising the NXF1-mRNA interaction.
Subsequently NXF1-P15 escorts the mRNA to the nuclear pore where it
interacts with nucleoporins via the NTF2L and Ubiquitin associated
domains. P15 is essential for the stabilisation of NTF2L and its
Fig. 2. The mRNA nuclear export pathway. The bulk of mRNA is exported into the cytoplasm by the TREX:NXF1 pathway. During transcription initial TREX complex
members are deposited upon the mRNA. Further processing such as capping and splicing results in further TREX deposition. Once an mRNA has matured the export
receptor NXF1 associates with the mRNA via TREX complex interactions. NXF1 guides the correctly packaged mRNA through the nuclear pore.
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interaction with NPC members [88,89].
8. The m6A pathway and nuclear export
The ﬁnal section of this review will cover the present data sug-
gesting an overlap between the m6A machinery and the TREX-NXF1
export pathway. Modiﬁcations of mRNA have previously been shown to
be required for nuclear export, the most famous example being the
requirement of the m7G cap and the accompanying CBC [74]. Evidence
has also been presented implicating ALYREF in regulating the export of
speciﬁc transcripts harbouring the internal mRNA modiﬁcation m5C
[90]. However, this study utilised RNA aﬃnity chromatography to
identify ALYREF and showed that it bound oligonucleotides bearing
m5C with greater aﬃnity than equivalent oligonucleotides lacking the
methylation modiﬁcation. This does not necessarily prove speciﬁcity
for m5C for ALYREF since the hydrophobicity of the aﬃnity column is
also altered with the methyl group addition and so in the absence of a
suitable control such as an m6A aﬃnity column we cannot be certain
that ALYREF speciﬁcally recognises m5C at present. It is not a stretch to
think the m6A pathway may have links to export, as mRNA maturation
events are closely coupled to TREX deposition and subsequent NXF1
dependent export [18,75,77]. A review of both the export and m6A
literature reveals a number of possible links between the two pathways
including associations between important regulatory players.
Historic work demonstrated the mRNA of Simian virus 40 (SV40)
harboured m6A modiﬁcations which appear to be added by host ma-
chinery whilst progressing through its replication cycle [91]. An in-
teresting observation from this early study was that cycloleucine
treatment, a methylation inhibitor, inhibited SV40 mRNA export. It was
noted the total amount of SV40 mRNA within the nucleus was un-
changed however the cytoplasmic levels of the SV40 mRNA were dra-
matically reduced, indicating a defect in export upon inhibitor treat-
ment [91]. Although it must be noted the use of cycloleucine will also
inhibit 5′ Cap formation, which is also detrimental to mRNA export.
More recent studies have demonstrated the role of the m6A and its
reader in the replication of HIV-1 and ZIKA viruses [92,93]. Also of
note, inhibition of S‑adenosylmethionine-dependent methyltransferase
reactions by S‑Tubercidinylhomocysteine (STH), triggered a delay in
mRNA export [94].
Further evidence of an overlap between mRNA export and m6A
appear in more recent literature and is brieﬂy summarised in Table 1
The knockdown of METTL3 caused a slowdown in the circadian clock
[12]. One of the reasons behind this was the reduced export of mature
mRNA of speciﬁc clock factors, Arntl and Per2 [12]. Therefore, the m6A
modiﬁcation was shown to be required for the eﬃcient export of spe-
ciﬁc mature mRNAs. Conversely, it was demonstrated by Poly(A)+ RNA
ﬂuorescence in situ hybridisation that ALKBH5 knockdown causes ex-
cess cytoplasmic accumulation of mRNA, however this was looking at
total Poly (A)+ RNA not just m6A containing and therefore may not be a
trait limited to m6A containing RNA [41].
Yet another indication of the overlap between the TREX complex
and the methylation machinery is demonstrated within a proteomic
study of the export adaptor ALYREF [78]. KIAA1429, a key member of
the methylation writer complex was found to associate with the export
adaptor [78]. A possible association between the two complexes was
also shown upon shotgun proteomic analysis of WTAP by mass spec-
trometry, identifying ALYREF and UAP56 as binding partners [28].
Further interesting binding partners were identiﬁed with WTAP that are
suspected to be involved with the nuclear mRNA export process in-
cluding: ERH which is known to associate with TREX [19] and the SR-
like proteins BCLAF1 and THRAP3 [28]. BCLAF1 is implicated in mRNA
export since its knockdown leads to an increase in cytoplasmic Poly
(A)+ mRNA [95] similar to that observed upon ALKBH5 knockdown
[41]. A recent study has shown that BCLAF1 and THRAP3 are required
for the eﬃcient splicing and export of DNA damage response mRNAs,
though the precise molecular role in export remains to be determined
[96]. The recently identiﬁed core member of the methyltransferase
complex ZC3H13 also interacts with the TREX complex, being found to
associate with ALYREF and THOC1 in multiple proteomics studies
[78,97].
RBM15 was also identiﬁed in the WTAP proteomics screen [28]
Fig. 3. The NXF1 mRNA handover event. Once an mRNA has matured and is
correctly packaged NXF1/P15 are recruited to initiate the ﬁnal stages of the
export pathway. Upon recruitment the mRNA binding domain (RBD) of NXF1 is
released from its intramolecular interactions with the NTFL2 domain via export
adaptor and co adapter binding. Once bound to the mRNA the NXF1:mRNA
complex is guided through the nuclear pore into the cytoplasm.
Table 1




Association with mRNA export Refs.




WTAP Associated with TREX (Co-IP and Mass spec)
Associated with SR-like proteins (BCLAF1/
TRAP150)
WTAP/KIAA1429 knockdown resulted in




KIAA1429 Associated with core TREX members
WTAP/KIAA1429 knockdown resulted in
defective mRNA export for speciﬁc transcripts
[22,78]
[22]
ZC3H13 Associated with ALYREF and THOC5 [78,98]
RBM15 Knockdown results in an export defect
Acts as an adaptor within NXF1/p15 pathway




YTHDC1 Knockdown resulted in mRNA export defect
of speciﬁc transcripts.





ALKBH5 Knockdown results in increased PolyA+ RNA
cytoplasmic accumulation.
[41]
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which was later found to play a role in the m6A pathway [13]. Strik-
ingly, RBM15 is also a bona ﬁde member of the NXF1-P15 export
pathway [98–100]. Knockdown of RBM15 results in cytoplasmic de-
pletion and nuclear accumulation of mRNA [99]. RBM15 binds to
NXF1, speciﬁcally NXF1s NTF2L domain [100]. RBM15 binding to
NXF1 NTF2L domain suggests it may act as an export co-adaptor such
as THOC5 and CHTOP, aiding in NXF1 loading on the mRNA [20].
RBM15 also associates with export adaptor ALYREF, but not with the
core TREX component UAP56, suggesting RBM15 plays a role in the
later stages of mRNA export [78,99,100]. Together these data showing
multiple interactions between the core of the mRNA export machinery
(TREX-NXF1) and proteins implicated in the m6A modiﬁcation strongly
suggests a functional connection between the two processes.
Two recent studies have now started to uncover the molecular
mechanisms connecting the m6A modiﬁcation and mRNA export,
summarised in Fig. 4. In the ﬁrst study, YTHDC1 was shown to interact
with SRSF3 which can act as an mRNA export adaptor [70]. SRSF3 has
previously been shown to bind NXF1 and act as a novel route for
loading NXF1 onto the mRNP [84]. Knockdown of YTHDC1 or SRSF3
led to a nuclear export block for a common set of transcripts suggesting
the two proteins act in the same pathway. Since SRSF3 binds NXF1 [84]
it was proposed that YTHDC1, in recruiting NXF1, was able to trigger
the selective export of m6A modiﬁed mRNAs [70]. Since SRSF3 only
provides the adaptor function to unlock NXF1 and allow its stable
binding to mRNAs, the co-adaptor function may be supplied by TREX.
Alternatively, an intriguing possibility is that RBM15 might provide the
co-adaptor function since it associates with both TREX and the m6A
methylation machinery. Furthermore, it associates with NXF1 via the
same domain used by co-adaptors, though this possibility remains to be
tested. The second study showed that the TREX complex associates with
the m6A writer machinery (WTAP, KIAA1429, METTL3, METTL14) and
TREX deposition on speciﬁc m6A modiﬁed mRNAs requires the m6A
writer complex [22]. The combined knockdown of WTAP/KIAA1429
led to an mRNA export block for a speciﬁc group of transcripts, which
had largely been shown to be m6A modiﬁed in previous studies [22].
Moreover, this study showed that only a small proportion of mRNAs
showed altered splicing following WTAP/KIAA1429 knockdown, con-
ﬁrming that the export block observed for many transcripts was not
caused by defective splicing. This study further conﬁrmed that YTHDC1
is required for the eﬃcient export of speciﬁc mRNAs and demonstrated
that knockdown of TREX in cells led to reduced levels of YTHDC1 as-
sociated with the mRNP, suggesting that TREX stabilises YTHDC1
binding to mRNA [22]. Together these two studies show that m6A plays
an important role in mRNA export.
9. Concluding remarks
The recent explosion of m6A literature has revealed a number of
exciting regulatory mechanisms that appear dependent on the addition
of the modiﬁcation. However, the literature does present a number of
conﬂicting views on the role of m6A within splicing. There are some
clear examples where m6A plays a role in splicing decisions, such as
YTHDC1-m6A-SRSF3, HNRNPC-m6A-switch and Drosophila sex de-
termination splicing mechanisms [11,51,66]. However, the recent
identiﬁcation of m6A not clustering near splice sites and knockout of
METTL3 resulting in minimal splicing changes [5] does suggest that
m6A regulation of splicing may be restricted to a limited set of tran-
scripts. Furthermore the actions of the m6A proteins may be drastically
diﬀerent depending on cellular context, for example its role in sper-
matocytes compared to mRNA half-life in HeLa cells [5,41]. Going
forward it will be important to begin to dissect the function for each
member of the methyltransferase complex, as it may well be possible
they have many roles within mRNA biogenesis, and these role may not
all be linked with m6A deposition. An interesting example of this was
presented above with ZC3H13 where it appears to exist in two separate
complexes with one devoid of METTL3/14. The METTL3/14 lacking
complex may harbour separate functions from m6A deposition, how-
ever knocking down ZC3H13, or WTAP/KIAA1429, will disrupt these
functions along with m6A deposition and dissecting these two activities
may be diﬃcult [22,25]. Another example is RBM15 having export
defects upon knockdown but also impairing m6A addition [13,100].
The question will be: are we seeing an export defect due to removing
RBM15s interactions with NXF1 or due to the lack of m6A deposition or
both? The dynamic aspect of the m6A modiﬁcation may not be the
modiﬁcation itself but the proteins that are involved in its addition and
subsequent binding.
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